News
HRI London 2019 – Call for Abstracts closed
11 December 2018
HRI’s 4th International Research Conference will take place in London from 14-16 June 2019. The deadline for submitting abstracts has now passed and will not be extended.
Hear from the experts
Clinical benefits of individualised homeopathy for menopausal women with depression
Dr Emma Macías-Cortés discusses the remarkable results of a high quality double-blind, double-dummy superiority trial, comparing three test groups receiving homeopathy or fluoxetine or placebo, demonstrating the clinical benefits of individualised homeopathy for peri- and post-menopausal women with depression.
Hot off the press
Effectiveness of Homeopathic Medicines as Add-on to Institutional Management Protocol for Acute Encephalitis Syndrome in Children: An Open-Label Randomized Placebo-Controlled Trial
Oberai P, Varanasi R, Padmanabhan M, et al.
Homeopathy, 2018; 107(3): 161-171
Abstract
In the news
Homeopathy Research Institute (HRI) comment on controversial study of high-dilution Rhus toxicodendron
A recently published experimental study investigating the effects of high-dilution preparations of Rhus toxicodendron has sparked controversy in research circles. At the time of its publication, in September 2018, HRI received a significant number of enquiries due to the study’s apparent relationship with homeopathy.
EASAC statement on homeopathy
The European Academies’ Scientific Advisory Council (EASAC) recently published a statement on Homeopathic products and practices, the analysis and conclusions of which were based on supposedly ‘excellent science-based assessments already published by authoritative and impartial bodies.’
Evidence base highlight
Homeopathy in the treatment of depression: a systematic review Open Access
Viksveen P, Fibert P, Relton C.
Eur.J.Integr.Med., 2018; 22: 22-36
Full text
